Ontario Rett Syndrome Association was pleased to have Guest Speaker – Dr. Walter Kaufmann from Anavex Life Sciences to discuss ANAVEX2-73 clinical trial in Pediatric Patients With Rett Syndrome (EXCELLENCE) at the beginning of their 2022 Annual General Meeting.
2022 AGM Presentation with Dr. Walter Kaufmann from Anavex Life Sciences
Last Updated: 11/01/2022 by admin
Ontario Rett Syndrome Association was pleased to have Guest Speaker – Dr. Walter Kaufmann from Anavex Life Sciences to discuss ANAVEX2-73 clinical trial in Pediatric Patients With Rett Syndrome (EXCELLENCE) at the beginning of their 2022 Annual General Meeting.
Category: News